Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective - 15/07/23
Doi : 10.1016/j.jaad.2023.01.053
Jensen Yeung, MD a, b, c, d, ⁎ 
, Melinda J. Gooderham, MD c, e, f, H. Chih-Ho Hong, MD c, g, h, i, Charles Lynde, MD c, j, Vimal H. Prajapati, MD k, l, m, n, o, Perla Lansang, MD a, b, d, p, Irina Turchin, MD c, q, r, Marni Wiseman, MD c, s, t, Carolyn Jack, MD u, v, w, Michele Ramien, MD k, x, Kerri Purdy, MD y, Parbeer Grewal, MD z, aa
, Melinda J. Gooderham, MD c, e, f, H. Chih-Ho Hong, MD c, g, h, i, Charles Lynde, MD c, j, Vimal H. Prajapati, MD k, l, m, n, o, Perla Lansang, MD a, b, d, p, Irina Turchin, MD c, q, r, Marni Wiseman, MD c, s, t, Carolyn Jack, MD u, v, w, Michele Ramien, MD k, x, Kerri Purdy, MD y, Parbeer Grewal, MD z, aa a Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada
b Department of Medicine, University of Toronto, Toronto, Ontario, Canada
c Probity Medical Research Inc, Waterloo, Ontario, Canada
d Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada
e Queen's University, Kingston, Ontario, Canada
f Skin Centre for Dermatology, Peterborough, Ontario, Canada
g Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada
h Dr Chih-Ho Hong Medical Inc, Surrey, British Columbia, Canada
i Probity Medical Research Inc, Surrey, British Columbia, Canada
j Lynde Institute for Dermatology, Markham, Ontario, Canada
k Department of Medicine, University of Calgary, Calgary, Alberta, Canada
l Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada
m Dermatology Research Institute, Calgary, Alberta, Canada
n Skin Health & Wellness Centre, Calgary, Alberta, Canada
o Probity Medical Research Inc, Calgary, Alberta, Canada
p The Hospital for Sick Children, Toronto, Ontario, Canada
q Brunswick Dermatology Center, Fredericton, New Brunswick, Canada
r Dalhousie University, Halifax, Nova Scotia, Canada
s SKiNWISE Dermatology, Winnipeg, Manitoba, Canada
t Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
u Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada
v Infectious Diseases and Immunity in Global Health, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
w Innovaderm Research, Montreal, Quebec, Canada
x Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, Canada
y Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
z Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
aa Rejuvenation Dermatology, Edmonton, Alberta, Canada
∗Correspondence and reprint requests to: Jensen Yeung, MD, Department of Dermatology, Women's College Hospital, 76 Grenville St, Fifth Floor, Toronto, ON M5S 1B2, CanadaDepartment of DermatologyWomen's College Hospital76 Grenville StFifth FloorTorontoONM5S 1B2Canada
Key words : atopic dermatitis, disease control, eczema, pruritus, treat-to-target
| Funding sources: This work was supported by LEO Pharma. |
|
| IRB approval status: Not applicable. |
© 2023
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 2
P. 372-375 - août 2023 Retour au numéro
Article précédent
- Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis
- I-Ling Chen, Hsien-Yi Chiu
- Risk factors for development of skin cancer differ between allogenic and autogenic hematopoietic stem cell transplant recipients
- Chelsea Shope, Laura Andrews, Caroline Brailsford, Lara Wine Lee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?